1. HandS ECMO: Preliminary Experience With 'Hub and Spoke' Model in Neonates With Meconium Aspiration Syndrome
- Author
-
Fichera, Dario, Zanella, Fabio, Fabozzo, Assunta, Doglioni, Nicoletta, Trevisanuto, Daniele, Lolli, Elisabetta, Vida, Vladimiro, Ceccherini, Enrico, Ebraico, Agostino, Stellin, Giovanni, and Padalino, Massimo
- Subjects
Patient Care Team ,Hospitals, Rural ,Operative Time ,Biomedical Engineering ,Infant, Newborn ,Medicine (miscellaneous) ,Bioengineering ,Hub and Spoke ,Time-to-Treatment ,Biomaterials ,Meconium Aspiration Syndrome ,Neonate ,Extracorporeal Membrane Oxygenation ,Treatment Outcome ,Outcome Assessment, Health Care ,Humans ,Extracorporeal membrane oxygenation ,Meconium aspiration syndrome ,Outcome ,Follow-Up Studies ,Retrospective Studies - Abstract
We aim to evaluate clinical outcomes of emergent extracorporeal membrane oxygenation (ECMO) implantation in newborns with life-threatening meconium aspiration syndrome (MAS) in peripheral hospitals with Hub and Spoke (HandS) setting. We retrospectively reviewed all neonates presenting with MAS, with no other comorbidities, treated with HandS ECMO, in peripheral hospitals. Team activation time (TAT) was described as the time from first alerting call to ECMO support initiation. From May 2014 to December 2016, 4 patients met our inclusion criteria. In addition, 2 cases occurred on the same day, requiring a second simultaneous HandS ECMO team activation. All patients were younger than 8 days of life (1, 1, 4, and 7), with a mean BSA 0.21 ± 0.03m
- Published
- 2017